Literature DB >> 16552760

Association of the Tau haplotype with Parkinson's disease in the Greek population.

Liana Fidani1, Kallirhoe Kalinderi, Sevasti Bostantjopoulou, Jordi Clarimon, Antonis Goulas, Zoe Katsarou, John Hardy, Alexandros Kotsis.   

Abstract

We compared the distribution of the Tau H1 haplotype and related subhaplotypes in a group of clinically diagnosed Parkinson's disease patients (n = 133) and in control individuals (n = 113) from northern Greece. We were able to detect a statistically significant overrepresentation of the H1H1 genotype in our patient group (OR for H1H1 vs. H1H2 and H2H2: 1.73; 95% CI: 1.03-2.90; P = 0.037). The H1 subhaplotype significantly associated with the disease in our population was different from the one previously reported for a Norwegian population, suggesting that the nature of the association of Tau with Parkinson's disease is influenced by ethnic variation. (c) 2006 Movement Disorder Society.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16552760     DOI: 10.1002/mds.20864

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  9 in total

Review 1.  Tau and MAPT genetics in tauopathies and synucleinopathies.

Authors:  Etienne Leveille; Owen A Ross; Ziv Gan-Or
Journal:  Parkinsonism Relat Disord       Date:  2021-09-14       Impact factor: 4.402

2.  Genome-wide association study confirms SNPs in SNCA and the MAPT region as common risk factors for Parkinson disease.

Authors:  Todd L Edwards; William K Scott; Cherylyn Almonte; Amber Burt; Eric H Powell; Gary W Beecham; Liyong Wang; Stephan Züchner; Ioanna Konidari; Gaofeng Wang; Carlos Singer; Fatta Nahab; Burton Scott; Jeffrey M Stajich; Margaret Pericak-Vance; Jonathan Haines; Jeffery M Vance; Eden R Martin
Journal:  Ann Hum Genet       Date:  2010-01-08       Impact factor: 1.670

3.  Association analysis of MAPT H1 haplotype and subhaplotypes in Parkinson's disease.

Authors:  Cyrus P Zabetian; Carolyn M Hutter; Stewart A Factor; John G Nutt; Donald S Higgins; Alida Griffith; John W Roberts; Berta C Leis; Denise M Kay; Dora Yearout; Jennifer S Montimurro; Karen L Edwards; Ali Samii; Haydeh Payami
Journal:  Ann Neurol       Date:  2007-08       Impact factor: 10.422

Review 4.  Meta-analysis of the association between variants in MAPT and neurodegenerative diseases.

Authors:  Cheng-Cheng Zhang; Jun-Xia Zhu; Yu Wan; Lin Tan; Hui-Fu Wang; Jin-Tai Yu; Lan Tan
Journal:  Oncotarget       Date:  2017-07-04

5.  Role of MAPT mutations and haplotype in frontotemporal lobar degeneration in Northern Finland.

Authors:  Anna-Lotta Kaivorinne; Johanna Krüger; Katja Kuivaniemi; Hannu Tuominen; Virpi Moilanen; Kari Majamaa; Anne M Remes
Journal:  BMC Neurol       Date:  2008-12-17       Impact factor: 2.474

6.  Role of the H1 haplotype of microtubule-associated protein tau (MAPT) gene in Greek patients with Parkinson's disease.

Authors:  Nikolaos Refenes; Juliane Bolbrinker; Georgios Tagaris; Antonio Orlacchio; Nikolaos Drakoulis; Reinhold Kreutz
Journal:  BMC Neurol       Date:  2009-06-28       Impact factor: 2.474

7.  MAPT rs242562 and GSK3B rs334558 are associated with Parkinson's Disease in central China.

Authors:  Lan Yu; Jinsha Huang; Desheng Zhai; Ling Liu; Kexin Guo; Xi Long; Jing Xiong; Zhentao Zhang; Youpei Wang; Ying Zhao; Ping Wu; Dingan Wang; Zhicheng Lin; Jing Wu; Nian Xiong; Tao Wang
Journal:  BMC Neurosci       Date:  2014-04-29       Impact factor: 3.288

8.  Genetic Architecture of MAPT Gene Region in Parkinson Disease Subtypes.

Authors:  Esterina Pascale; Maria Elena Di Battista; Alfonso Rubino; Carlo Purcaro; Marcella Valente; Francesco Fattapposta; Giampiero Ferraguti; Giuseppe Meco
Journal:  Front Cell Neurosci       Date:  2016-04-11       Impact factor: 5.505

9.  Exploring the Effects of Genetic Variants on Clinical Profiles of Parkinson's Disease Assessed by the Unified Parkinson's Disease Rating Scale and the Hoehn-Yahr Stage.

Authors:  Chen Shi; Zheng Zheng; Qi Wang; Chaodong Wang; Dabao Zhang; Min Zhang; Piu Chan; Xiaomin Wang
Journal:  PLoS One       Date:  2016-06-14       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.